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Background: Conventional parameters such as aortic valve area, peak velocity and mean pressure gradient have been known to have limitations 
in patients with paradoxical low flow and/or low gradient aortic stenosis (AS). The aim of this study was to evaluate the prognostic value of 
valvuloarterial impedance (Zva) in patients with AS.
Methods: The clinical and echocardiographic data of 198 patients with AS were retrospectively reviewed. The Zva is calculated by dividing the 
estimated LV systolic pressure (systolic arterial pressure + mean transvalvular gradient) by the stroke volume indexed for the body surface area. The 
patients were subdivided into 3 groups according to the level of Zva (low group Zva <4.8, medium group 4.8≤Zva<6.3, high group ≥6.3 mmHg/ml/m2).
Results: Twenty-eight deceased were older (75.6 vs 66.0 yr, p<0.001) and had lower left ventricular ejection fraction (LVEF, 51.3% vs 56.9%, 
p=0.016) and higher Zva (6.60 vs 5.70 mmHg/ml/m2, p= 0.046). The risk of mortality was increased by 7.1-fold in moderate Zva group and by 
11.5-fold in high Zva group assessed by Cox proportional hazards model after adjusting for age, systolic blood pressure, LVEF and aortic valve area. 
Kaplan-Meier event free survival curve showed significantly different event rates (p=0.002, Figure).
Conclusions: Increased Zva is a useful marker of excessive LV hemodynamic load and poor prognosis. Zva may be useful to improve risk 
stratification and clinical decision making in patients with AS.
 
